Abstract
Purpose
Administration of remifentanil can be a reliable method for preventing airway reflex responses during emergence. We therefore investigated the effect of maintaining target controlled infusion (TCI) of remifentanil for smooth cLMA removal during emergence from desflurane–remifentanil anaesthesia.
Methods
Forty-one patients undergoing uretero-renoscopy under general anesthesia with desflurane and at 1–4 ng/ml TCI remifentanil infusion were randomly assigned to a control group (n = 20) or a remifentanil group (n = 21). At the end of the surgery, desflurane and remifentanil infusion were stopped in group C and remifentanil was maintained at the effect-site concentration of 1.5 ng/ml TCI in group R. When LMA removal was accomplished without coughing, teeth clenching, gross purposeful movements, breath holding, laryngospasm, and desaturation to SpO2 less than 90%, removal was regarded as smooth (successful). The emergence and recovery profiles were also evaluated.
Results
The incidence and number of complications (coughing, teeth clenching, gross purposeful movements, breath holding, laryngospasm, desaturation to SpO2 <90%) were significantly higher in the control group than in the remifentanil group (p = 0.002).
Conclusion
Maintaining effect-site TCI of remifentanil at 1.5 ng/ml during emergence from anaesthesia enabled smooth removal of cLMA without any delay in recovery time.
Similar content being viewed by others
References
Gataure PS, Latto IP, Rust S. Complications with associated with removal of the laryngeal mask airway: a comparison of removal in deeply anaesthetised versus awake patients. Can J Anaesth. 1995;42:1113–6.
Baird MB, Mayor AH, Goodwin AP. Removal of the laryngeal mask airway: factors affecting the incidence of post-operative adverse respiratory events in 300 patients. Eur J Anaesthesiol. 1999;16:251–6.
Nunez J, Hughes J, Wareham K, Asai T. Timing of removal of the laryngeal mask airway. Anaesthesia. 1998;53:126–30.
Diachun CAB, Tunink BP, Brock-Utne JG. Suppression of cough during emergence from general anaesthesia: laryngotracheal lidocaine through a modified endotracheal tube. J Clin Anesth. 2001;13:447–51.
Kapila A, Glass PS, Jacobs JR. Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology. 1995;83:968–75.
Egan TD. Target-controlled drug delivery: Progress toward and intravenous “vaporiser” and automated anesthetic administration. Anesthesiology. 2003;99:1214–9.
Lee JR, Lee YS, Kim CS, Kim SD, Kim HS. A comparison of the endtidal sevoflurane concentrations for removal of the laryngeal mask airway and laryngeal tube in anesthetised children. Anesth Analg. 2008;106:1122–5.
Aldrete JA. The post-anesthesia recovery score revisited. J Clin Anesth. 1995;7:89–91.
Hui JK, Critchley LA, Karmakar MK, Lam PK. Co-administration of alfentanil-propofol improves laryngeal mask airway insertion compared to fentanyl-propofol. Can J Anaesth. 2002;49:508–12.
Bouvet L, Da-Col X, Rimmelé T, Allaouchiche B, Chassard D, Boselli E. Optimal remifentanil dose for laryngeal mask airway insertion when co-administered with a single standard dose of propofol. Can J Anaesth. 2010;57:222–9.
Kamei J, Tanihara H, Kasuya Y. Antitussive effects of two specific k-opioid agonists U50, 488H, U62, 066E in rats. Eur J Pharmacol. 1990;187:281–6.
Spina D, McFadzean I, Bertram FK, Page CP. Peripheral mechanisms II: the pharmacology of peripherally active antitussive drugs. In: Handbook of experimental pharmacology, vol. 187, pp. 155–86, 2009.
Tagaito Y, Isono S, Nishino T. Upper airway reflexes during a combination of propofol and fentanyl anesthesia. Anesthesiology. 1998;88:1459–66.
Egan TD, Minto CF, Hermann DJ, Barr J, Muir KT, Shafer SL. Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. Anesthesiology. 1996;84:821–33.
Moerman AT, Herregods LL, De Vos MM, Mortier EP, Struys MM. Manual versus target-controlled infusion remifentanil administration in spontaneously breathing patients. Anesth Analg. 2009;108:828–34.
Aouad MT, Al-Alami AA, Nasr VG, Souki FG, Zbeidy RA, Siddik-Sayyid SM. The effect of low-dose remifentanil on responses to the endotracheal tube during emergence from general anesthesia. Anesth Analg. 2009;108:1157–60.
Lee JH, Koo BN, Jeong JJ, Kim HS, Lee JR. Differential effects of lidocaine and remifentanil on response to the tracheal tube during emergence from general anaesthesia. Br J Anaesth. 2011;106:410–5.
Jun NH, Lee JW, Song JW, Koh JC, Park WS, Shim YH. Optimal effect-site concentration of remifentanil for preventing cough during emergence from sevoflurane–remifentanil anaesthesia. Anaesthesia. 2010;65:930–5.
Bowdle TA, Camporesi EM, Maysick L, Hogue CW Jr, Miguel RV, Pitts M, Streisand JB. A multicenter evaluation of remifentanil for early postoperative analgesia. Anesth Analg. 1996;83:1292–7.
Acknowledgments
This trial was supported by the Ministry of Health, Diskapi Yildirim Beyazit Research, and the Training Hospital Department of Anesthesiology, Ankara, Turkey.
Conflict of interest
No author has a conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
ClinicalTrials.gov (NCT01303627).
About this article
Cite this article
Özkan, D., Ergil, J., Alptekin, A. et al. Target controlled remifentanil infusion for smooth laryngeal mask airway removal during emergence from desflurane–remifentanil anesthesia. J Anesth 26, 369–374 (2012). https://doi.org/10.1007/s00540-012-1346-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00540-012-1346-1